Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for ...

Please provide your email address to receive an email when new articles are posted on . A London-based biotech firm has announced a collaboration and licensing agreement with a Japanese pharmaceutical ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

RNA in cells performs an astounding number of functions. Messenger RNA carries the sequences of active genes to cellular machinery that turns it into proteins. And transfer RNA molecules are an ...

The discovery of siRNA and its role in RNAi was a groundbreaking finding in the field of molecular biology. In 1998, Andrew Fire and Craig Mello published a seminal paper describing the phenomenon of ...

The modulation of RNA splicing by small molecules has emerged as a promising strategy for treating pathogenic infections, human genetic diseases, and cancer; however, the principles by which splicing ...

(Nanowerk Spotlight) Nucleic acids are becoming increasingly popular for assembling nanoscale structures, thanks to their programmable dimensionality and direct applications in the biological field.

Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.